Equities

Paragon Care Ltd

Paragon Care Ltd

Actions
Health CareMedical Equipment and Services
  • Price (EUR)0.183
  • Today's Change0.00 / 0.00%
  • Shares traded45.00k
  • 1 Year change+22.82%
  • Beta--
Data delayed at least 15 minutes, as of May 02 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Paragon Care Limited is an Australia-based company. It is engaged in the supply of durable medical equipment, medical devices and consumable medical products and maintenance of technical medical equipment to the health, aged care and veterinary markets throughout Australia. Its segments include Diagnostic and Scientific, Devices, Capital and Consumables, and Service and Technology. Diagnostic and Scientific segment incorporates blood bank diagnostics manufacturer, clinical pathology diagnostics distribution and scientific and research and development (R&D) laboratory equipment distribution. Devices Segment incorporates ophthalmology and optometry, orthopedics, pain management, infection prevention and ortho biologics. Capital and Consumables segment includes medical, surgical and veterinary services. Service and Technology segment includes offering from biomedical devices to high end capital equipment, service support and technology management and service partnership with brands.

  • Revenue in AUD (TTM)317.39m
  • Net income in AUD10.31m
  • Incorporated1994
  • Employees0.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
PGC:ASX since
announced
Transaction
value
CH2 Holdings Pty LtdAnnounced01 Mar 202401 Mar 2024Announced60.00%125.63m
Data delayed at least 20 minutes, as of May 03 2024 05:38 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.